GCP Home
IntroductionReasons to ProtectLicensing Strategies3rd Party IPAccess to TechnologyAdministrative Issues
The Impact of Genetic Resource Policies on Research Institutes
Click here to view the animation of the round-table discussion between I.D. Termin, Barbara Reed, Eugene O'Toole, Fina T'Odinga and Marc Atere.

For those who do not have a fast enough connection or with whom the Flash-drive doesn’t work, read the conversation here
Back to top
Assignment
Which persons from the animation do you have in your organization? Which ‘role’ do you have in your organization? Reflect on the discussion in the animation in your own situation and describe whether you recognize yourself in ‘your role’ in the play.
Provide your answer below. You can edit this until the result has been evaluated by a coach.
Allow other participants to see my answer.

Results sent in by others:

Sent on 2007-04-30 22:20:23 by Maria del Rosario Falcon
Plant research work is changing, in the past the only concern was that the plant breeding work must be the best for the characteristic we need for the new material result form the work, this days we have to worry if the clone we are using is register as an IPR.
This give more concern and work to the plant breeders, the same also this days that a scientific need to look after the money its work is demanding; thinking in the best equipments each days are in the market used for the best results in the research work.
There are some scientific people that this kind of work takes them to a stress because they need to worry a lot about their research and now one more thing driving with the politics at the center and the laws at the country where they are doing the research.
I think that these issues are going to change and in this way every body must be aware of the topics of IPR.
Is a little difficult to give names but there are some scientific at my center that they don’t mind about rules they don’t want to complicate their lives in policies they only want to think on the results of their research, fortunately this days the scientific people are increasing in number and are becoming more understanding on this topics
Evaluated on 2007-05-02 00:00:00 by Niels Louwaars
Maria, I don't think we need names about people who don't care about the rights of other scientists. You clearly depict some of the problems that science has to deal with, but I wonder whether an increased understanding of the topics is leading to more effective research for development or not . . .
Sent on 2007-05-03 12:19:53 by Emmanuel Okogbenin
WE have a head of crop breeding program, a biotechnologist and a business officer. I have a role to play in both breeding and biotechnology. Biotechnology activities are mainly supported by CIAT. Research products used in my institute are those mainly provide by the CG centers which are easily accessible and devoids of IP issues. My institute is public funded and PBR has not been so largely stressed becaue of the need to ensure that end-users (mainly resource poor farmers) of our technology (especially plant varieties). Howver, IP issues are beginning to get some mention in my system but precise policies by the Nigeian government have not yet been spelt out. The business offcier is only involved in limited commercial activities in the provision of the developed research product from my institute to the private and public sector for their use. It is more related to dissemination of new technology. For expample, the institute expends a lot of resources to multiply new varities and sell the varieties (as planting materials to famers and firms) for their use and industries. it is mainly to recoup cost incurred in this actvitiy and to generate some revenue. However the farmers and firms can re-sell their products for commercial purposes. So it has no bearing to IP issues (UPOV or patency) concerning generation of income for institutions. Emmanuel
Evaluated on 2007-05-07 00:00:00 by Niels Louwaars
Emmanuel, I understand that the institute earns money on selling seed without IPRs on them, so that buyers are free to re-use (and sell) farm-saved seed or even commercialise them. I wonder whether the institute would welcome the introduction of PVP, which potentially could multiply the earnings (and change the research direction to maximise earnings) - or that it would renounce the profit criterion in favour of its focus on poverty alleviation and development.
Sent on 2007-05-07 01:57:37 by Humberto Gómez
My role might be similar to that of Mark Atere, the business development officer. However, at the stage we are in, I identify my activities very much with the concerns of Mrs. Fina T'Odinga, because we must make sure to have legal coverage in every action, to avoid getting in trouble and forced to stop abruptly.

I am hopeful that when I feel confident of having taken proper care of the legal aspects, and have become familiar with them, then my focus would move to other issues, like seeking a better synchronization of our services with our beneficiaries needs. We use free access technology, mostly developed within our organization, we could use third parties technology as long as their owners provide us with clean and free access for our beneficiaries. We also are willing to join the development of technology with several partners as long as the outcome becomes a public good.

We seek to generate high value products (data) out of the germplasm of our participants, for their use with no “strings attached”, so that they can make their cultivar development activities more effective and faster. The decision making process of any IP issue in their breeding material is their concern, because they own it. Our mandate is to spread molecular markers technology in very effective ways, with the goal of improving food security, scientific capacity and wealth creation in poverty stricken locations. We also encourage resources sharing as a strategy to make faster progress.

Evaluated on 2007-05-07 00:00:00 by Niels Louwaars
Dear Humberto, i would like to hear from you whether you think that it will be possible to keep the free access principle in all cases, particularly when technologies may carry multiple product and process patents + MTA rules. And especially hwat will be needed to secure this freedom-to-operate.
Sent on 2007-06-02 03:03:02 by Feng Ling Fu
Acturally in our institute,there are seldom discussion be held about the CBD regulation and opinion about PGR transfer and IPR. but early of 2000 year, the seed law came out, many regulations consist with the principle of the WTO, depicits the rights of nation government, breeders, seed companies and famers.
what we worried is the IPR rights involved in the research technology, many researchers in agricultural university take the method in their research from the papers published in international journals, some of the research results were applicated in production. Now I really want aware which technologies that involved in biology field, especially in agricultural research and breeding, have been IPR protected. like the molecular markers technology be mentioned in above course part, it is commonly used in breeding research, is it really be protected by IPR law, what is the details about this technology? truely, we have the awareness with the determination of which technolgy, methods would be applicated in research subject. but the detail law administratored by nation government and international organization, we need know more.
Back to top
The Purpose Of This Module
The developments and agreements at the international level that are relevant for plant breeders and their translation to national laws and regulations have been presented in Part 2, sections 1 and 2 of this course. The current Part 3 will deal with the response of public research institutions to these policies and laws. To what extent are these regulations relevant for public institutions, and which choices can be made in dealing with these?

The first part of this module ('Introduction and IPRs') will deal with IPRs and in particular with plant breeder’s rights and patents.
The second part ('Access to PGR and TK') will deal with access to genetic resources and especially with MTAs, and to a lesser extent with traditional knowledge.

In both sections you will have to deal with your own rights on technologies and materials developed by the institute itself and 3rd party rights on technologies and materials that we use in our research.
Previous Next
glossary backpack sitemap